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Abstract
               Troponin elevation is usually synonymous with acute coronary syndrome (ACS). 
Although sensitive for ACS, the elevation of serum troponin, in the absence of clinical evidence 
of ischemia, should prompt a search for other etiologies of myocardial necrosis. In fact, elevated 
values of troponin are correlated with myocardial necrosis even though it does not discriminate 
the mechanism involved. We report a series of seven patients (age range 18-67 years), who 
presented with complaints of chest discomfort and were found to have regular supraventricular 
tachycardia (5 patients) and one patient each with atrial fibrillation and ventricular tachycardia. 
All these patients had elevated troponin I and underwent coronary angiography that revealed 
normal epicardial coronary arteries. This is first case series in which all patients underwent 
coronary angiography and none of the patients was hemodynamically unstable at the time of 
presentation. Patients with elevated troponin due to conditions other   than ACS can receive 
inappropriate and delayed definitive diagnosis and treatment.
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Introduction
            Troponin elevation usually signifies some myocardial damage and is associated with 
significant obstructive coronary artery disease. There are multiple conditions that can cause 
elevation of troponin besides myocardial ischemia like sepsis, renal failure, decompensated heart 
failure, pulmonary embolism, coronary vasospasm, prolonged hypotension and tachycardias 
associated with hypotension to mention few. Although there have been multiple case reports of 
troponin elevation associated with tachycardias,  coronary artery disease was ruled out either by 
stress test or by coronary angiography. We report a case series of 7 patients with different kinds 
of   tachycardias   and   troponin   elevation   who   underwent   coronary   angiography   and   were 
hemodynamically   stable.                                                                              
Method
               Six patients of supraventricular tachycardias of different duration and one case of 
sustained   ventricular   tachycardia   were   found   in   our   database.   All   cases   presented   with 
palpitations and chest discomfort of different duration. Patients underwent routine laboratory 
investigations and all of them had two-dimensional echocardiography. All patients were found to 
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have elevated troponin I. There were three cases of accessory pathway mediated tachycardia 
(AVRT), two cases of atrioventricular-nodal reentrant tachycardia (AVNRT) and one case each 
of atrial fibrillation (AF) with fast ventricular response and ventricular tachycardia (VT). All 
patients underwent coronary angiography and had normal coronary arteries. Five patients (3 
AVRT and 2 AVNRT) underwent successful radiofrequency ablation. One with atrial fibrillation 
was subsequently cardioverted after coronary angiography and placed on sotalol. The patient 
who presented with ventricular tachycardia was placed on amiodarone and had a biventricular 
ICD implanted for non-ischemic cardiomyopathy. All patients had elevation of Troponin I 
(Normal 0.00-0.04 ng/ml). Table 1 shows the patient characteristics.
Table 1: Baseline characteristics of the patients.
Discussion
            The joint committee of the European Society of Cardiology, the American College of 
Cardiology, and the American Heart Association has accepted the measurement of troponin T 
and I in serum as the standard biomarker for the diagnosis of acute myocardial infarction and for 
diagnosis and management of acute coronary syndromes1-3. However, the ACC/AHA guidelines 
also indicate that the myocardial necrosis signified by troponin elevation may not necessarily be 
due to atherosclerotic coronary artery disease and that myocardial infarction should therefore be 
diagnosed in conjunction with other supportive evidence. There have been few reports of 
troponin elevation in various tachyarrythmias. Bakshi4 and colleagues in his study of 21 patients 
with troponin elevation with normal angiogram found that tachycardia was the culprit in 28% of 
patients. Zellweger5 and associates reported 4 patients with supraventricular tachycardia who 
were found to have elevated troponin levels without evidence of coronary artery disease. 
However, in their report, only two patients were taken for coronary angiography and two had 
stress tests. Redfearna etal6, reports seven patients of troponin elevation with supraventricular 
tachycardia. All these patients underwent coronary angiography and had normal epicardial 
coronary arteries. However, in his report two patients had hemodynamic compromise. These 
reports illustrate that troponins can be released because of tachycardia alone in the absence of 
myodepressive factors, inflammatory mediators, and coronary artery disease. We believe our 
series of patients with troponin elevation from various tachycardias with angiographically proven 
normal coronary vessels and without any hemodynamic compromise will be the largest one 
published   till   date.                                                                          
            All patients in our series underwent coronary angiography and had normal epicardial 
vessels. None of our patient was hemodynamically unstable and therefore the troponin rise in our 
series  was  a  direct  result  of  tachycardia.                                                                
            The exact mechanism for troponin elevation during a tachycardia remains unknown. 
However,   the   most   likely   mechanism   may   be   shortening   of   diastole   with   subsequent 
subendocardial   ischemia1.   Coronary   perfusion   especially   to   subendocardium   occurs 
predominantly during diastole. Increase in heart rate causes diastole to shorten with subsequent 
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decrease in subendocardial perfusion. Another, possible mechanism for tachycardia mediated 
troponin elevation is myocardial stretch. Higgins et al7 and Qi et al8 found a direct correlation 
between rise in cardiac BNP (B-Type Natriuretic Peptide) and troponins in patients with various 
tachycardias. This might be a limitation in some of the studies reported including ours, as BNP 
levels were not obtained. There was no relation of type and duration of the tachycardia with peak 
troponin   elevation.                                                                                  
Conclusion
            The patients admitted within the framework of tachyarrhythmia without hemodynamic 
instability, the decision whether to obtain serum markers of myocardial ischemia should cover a 
comprehensive clinical context. Patients with elevated troponin due to conditions other than ACS 
can receive inappropriate and delayed definitive diagnosis and treatment. 
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